Possibilities of using phytoestrogens in the treatment of menopausal syndrome

In the civilized world, there is a dilemma on how to relate to aging - to perceive it as a natural process characteristic of any living organism or to elevate it to the rank of a disease in order to try to develop methods of “treatment”. Age-related changes in a woman begin at about 40 years old and are associated with various hormonal changes. Often this stage in the life of the fair sex does not go unnoticed, it makes unpleasant corrections to the lifestyle with the need to change established habits and rules. Interestingly, in the era of information technology, women are not always sufficiently informed about the main age-related changes in their own body. The primary task of clinicians is to timely reveal the secrets of women’s health and help them adapt to the upcoming changes. Fluctuations in hormonal status are observed throughout a woman’s life. Contrary to the common misconception among women, it is completely incorrect to identify menopause with old age, because the hormonal function in women begins to fade long before the true aging. Climax is a multistage period of life, during which all systems of the female body adapt to the new conditions of estrogen deficiency.

In the treatment of climacteric disorders hormonal therapy with synthetic analogues of female sex hormones is used. Only preparations of bioidentical hormones have a real protective effect on metabolic disorders, osteoporosis, cardiovascular complications, cognitive disorders. According to clinical recommendations, approaches to the treatment of menopausal disorders should be clearly customized to the identified risks and expected benefits. Choosing the optimal composition and regime of MHT allows to increase efficiency and minimize possible risks. Clinicians should not forget about situations where there are restrictions or contraindications to the use of MHT. The presence of absolute and relative contraindications to MHT, as well as widespread hormoneophobia in our country in women have led to the development of alternative methods of treatment of menopausal disorders.

1. Fuentes N., SiLveyra Р. Chapter Three - Estrogen receptor signaling mechanisms. Adv Protein Chem Struct Biol. 2019;116:135-170. doi: 10.1016/bs.apcsb.2019.01.001.

2. HarLow S.D., Gass M., HaLL J.E., Lobo R., Maki P., Rebar R.W. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19(4):387-395. doi: 10.1097/gme.0b013e31824d8f40.

3. ZeLeke B.M., BeLL RJ., BiLLah B., Davis S.R. Vasomotor and sexuaL symptoms in oLder AustraLian women: a cross-sectionaL study. Fertil Steril. 2016;105(1):149-155eL. doi: 10.1016/j.fertnstert.2015.09.017.

4. Ossewaarde M.E., Bots M.L, Verbeek A.L.M., Peeters P.H.M., van der Graaf Y., Grobbe D.E., van der Schouw Y.T. Age at Menopause, Cause-Specific MortaLity and TotaL Life Expectancy. Epidemiology. 2005;16(4):556-562. doi: 10.1097/01.ede.0000165392.35273.d4.

5. Biglia N., Cagnacci A., Gambacciani M., LeLLo S., Maffei S., Nappi R.E. Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases? Climacteric. 2017;20(4):306-312. doi: 10.1080/13697137.2017.1315089.

6. Thurston R., Joffe H. Vasomotor symptoms and menopause: findings from the Study of Women's Health across the Nation. Obstet Gynecol Clin North Am. 2011;38(3):489-501. doi: 10.1016/j.ogc.2011.05.006.

7. Silveira J., Clapauch R., Souza M., Bouskela E. Hot flashes: emerging cardiovascular risk factors in recent and late postmenopause and their association with higher blood pressure. Menopause. 2016;23(8):846-855. doi: 10.1097/GME.0000000000000641.

8. Muka T., Oliver-Williams C., Colpani V., Kunutsor S., Chowdhury S., Chow-dhury R. et al. Association of vasomotor and other menopausal symptoms with risk of cardiovascular disease: a systematic review and meta-analysis. PLoSOne. 2016;11(6):e0157417. doi: 10.1371/journal.pone.0157417.

9. Thurston R., Johnson B., Pepine C., Shufelt C., Reis S., Kelsey S. et al. Early-onset menopausal vasomotor symptoms are associated with endothelial dysfunction: the National Heart Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. J Am Coll Card. 2015;65(10S)A15 12. doi: 10.1016/S0735-1097(15)61512-1.

10. Sarrel PM. Women, work, and menopause. Menopause. 2012;19(3):250-252. doi: 10.1097/gme.0b013e3182434e0c.

11. Yakushevskaya O.V. The menopause - a new chapter giving women a lust for life. Meditsinskiy sovet = Medical Council. 2019;(7):126-132. (In Russ.) doi: 10.21518/2079-701X-2019-7-126-132.

12. Yakushevskaya O.V. Alternative therapies for menopausal disorders. Meditsinskiy sovet = Medical Council. 2019;(13):131-136. (In Russ.) doi: 10.21518/2079-701X-2019-13-131-136.

13. Beck V., Rohr U., Jungbauer A. Phytoestrogens Derived From Red Clover: An Alternative to Estrogen Replacement Therapy? J Steroid Biochem Mol Biol. 2005;94(5):499-518. doi: 10.1016/j.jsbmb.2004.12.038.

14. Einer-Jensen N., Zhao J., Andersen K.P, Kristoffersen K. Cimicifuga and Melbrosia lack oestrogenic effects in mice and rats. Maturitas. 1996;25(2):149-153. doi: 10.1016/0378-5122(96)01052-3.

15. Maki P.M. Verbal memory and menopause. Maturitas. 2015;82(3):288-290. doi: 10.1016/j.maturitas.2015.07.023.

16. Ohmichi M., Tasaka K., Kurachi H., Murata Y. Molecular mechanism of action of Selective Estrogen Receptor Modulator in target tissues. Endocr J. 2005;52(2):161-167. doi: 10.1507/endocrj.52.161.

17. Ghazanfarpour M., Sadeghi R., Latifnejad Roudsari R., Mirzaii Najmabadi M., Mousavi Bazaz M., Abdolahian S., Khadivzadeh T. Effects of red clover on hot flash and circulating hormone concentrations in menopausal women: a systematic review and meta-analysis. Avicenna J Phytomed. 2015;5(6):498511. Available at: https://www.researchgate.net/publication/283461563_Effects_of_red_clover_on_hot_flash_and_circulating_hormone_concentra-tions_in_menopausal_women_a_systematic_review_and_meta-analysis.

18. Luisa A., Dominguesa F., Pereira L. Effects of red clover on perimenopau-sal and postmenopausal women's blood lipid profile: A meta-analysis. Climacteric. 2018;21(5):446-453. doi: 10.1080/13697137.2018.1501673.